FindTrial
Sign In

COVID-19 and cancer chemotherapy

COVID-19 and cancer chemotherapy- collate data on treatment patterns, short-term outcomes and patient experience

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025217
Enrollment
200
Registered
2020-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: C00-D49- Neoplasms

Interventions

None listed

Sponsors

Dr Bhawna Sirohi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult (more than 18 years of age) cancer patients currently on active chemotherapy treatment at Max Institute of Cancer Care

Exclusion criteria

Exclusion criteria: Patients not able to give consent Patient less than 18 years age on the day of enrollment

Design outcomes

Primary

MeasureTime frame
To describe change in cancer treatment patterns as a result of the pandemicTimepoint: 6 months from start of enrollment—

Secondary

MeasureTime frame
To assess impact on short-term morbidity Assess impact on patient experience (questionnaire based)Timepoint: End of study—

Countries

India

Contacts

Public ContactDr Bhawna Sirohi

Max healthcare

bhawna.sirohi13@gmail.com9756999976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026